Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations

J Allergy Clin Immunol. 2023 Sep;152(3):815-817. doi: 10.1016/j.jaci.2023.05.016. Epub 2023 Jun 26.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Monoclonal / genetics
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Neutralizing / genetics
  • Candidiasis, Chronic Mucocutaneous* / genetics
  • Gain of Function Mutation
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • STAT1 Transcription Factor / genetics
  • STAT1 Transcription Factor / metabolism

Substances

  • Emapalumab
  • Antibodies, Monoclonal
  • Antibodies, Neutralizing
  • STAT1 Transcription Factor
  • STAT1 protein, human